Company Search:
Advanced Search
Sponsored Links
Mesoblast Ltd Company Snapshot
Mesoblast Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mesoblast Ltd with three other companies in this sector in AUSTRALIA : Cogstate Ltd (2020 sales of 35.36 million Australian Dollars [US$27.24 million] of which 89% was Clinical Trials), Idt Australia Limited. (14.17 million Australian Dollars [US$10.92 million] ), and Clinuvel Pharmaceuticals Limited (33.13 million Australian Dollars [US$25.52 million] of which 100% was Biotechnology).

Sales Analysis. Sales levels dropped significantly in the third fiscal quarter of 2021 versus the previous year's third quarter. During the third fiscal quarter of 2021, sales at Mesoblast Ltd totalled A$2.50 million. This is a drop of 86.2% from the A$18.20 million in sales at the company during the third quarter in 2020. During the first three quarters of 2021, sales totalled A$7.36 million, which is 84.3% lower than through the first three fiscal quarters of 2020. During the year ended June of 2020, sales at Mesoblast Ltd were A$47.97 million (US$36.96 million). This is an increase of 105.0% versus 2019, when the company's sales were A$23.40 million. This was the third consecutive year of growth at Mesoblast Ltd.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Mesoblast Ltd
  Stock Performance Chart for Mesoblast Ltd
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): 2.15
(Figures in Australian Dollars)
1 Week 16.2%   13 Weeks 23.6%  
4 Weeks -8.5%   52 Weeks -40.3%  
Mesoblast Ltd Key Data:
  Ticker: MSB Country: Australia
  Exchanges: OTC BLN ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 47,974,823
(Year Ending Jan 2021).
Employees: 102
  Currency: Australian Dollars Market Cap: 1,391,908,755
  Fiscal Yr Ends: June Shares Outstanding: 647,399,421
  Share Type: Ordinary Closely Held Shares: 92,118,639
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.